- CP-466722
-
- $68.00 / 5mg
-
2025-11-02
- CAS:1080622-86-1
- Min. Order:
- Purity: 99.85%
- Supply Ability: 10g
|
| | CP466722 Basic information |
| Product Name: | CP466722 | | Synonyms: | CP466722;1-(6,7-Dimethoxy-4-quinazolinyl)-3-(2-pyridinyl)-1H-1,2,4-triazol-5-amine;2-(6,7-dimethoxyquinazolin-4-yl)-5-(pyridin-2-yl)-2H-1,2,4-triazol-3-amine;1-(6,7-Dimethoxy-4-quinazolinyl)-3-(2-pyridinyl)-1H-1,2,4-triazol-5-amine CP 466722;2-(6,7-dimethoxyquinazolin-4-yl)-5-pyridin-2-yl-1,2,4-triazol-3-amine;CP-466722;CP466722;1-(6,7-Dimethoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine;CP466722;CP 466722;CP-466722 | | CAS: | 1080622-86-1 | | MF: | C17H15N7O2 | | MW: | 349.35 | | EINECS: | 808-414-0 | | Product Categories: | Inhibitors | | Mol File: | 1080622-86-1.mol |  |
| | CP466722 Chemical Properties |
| Boiling point | 642.3±65.0 °C(Predicted) | | density | 1.48 | | storage temp. | Keep in dark place,Sealed in dry,2-8°C | | solubility | DMSO: soluble0.5mg/mL, clear (warmed) | | pka | 0.00±0.19(Predicted) | | form | powder | | color | white to beige |
| Hazard Codes | Xn | | Risk Statements | 22 | | WGK Germany | 3 |
| | CP466722 Usage And Synthesis |
| Description | CP 466,722 is an inhibitor of ataxia-telangiectasia mutated (ATM) kinase that inhibits ionizing radiation-induced ATM autophosphorylation and phosphorylation of the ATM targets SMC1, Chk2, and p53 in HeLa cells when used at a concentration of 10 μM. It is selective for ATM over PI3K and PIKK in HFF(hTERT) and A-T(hTERT) fibroblasts, respectively. CP 466,722 decreases cell survival in response to ionizing radiation in HeLa cells. It is also cytotoxic to MCF-7 and SKBr-3 breast cancer cells (IC50s = 16.92 and 12.78 μM, respectively). | | Uses | CP466722 is a competetive, reversible inhbitor of Ataxia telangiectasia (A-T) mutated (ATM) kinase | | Definition | ChEBI: 2-(6,7-dimethoxy-4-quinazolinyl)-5-(2-pyridinyl)-1,2,4-triazol-3-amine is a member of quinazolines. | | target | ATM | | IC 50 | ATM: 4.1 μM (IC50) | | references | [1]. guo, k., et al., development of a cell-based, high-throughput screening assay for atm kinase inhibitors. j biomol screen, 2014. 19(4): p. 538-46.
[2]. nadkarni, a., et al., atm inhibitor ku-55933 increases the tmz responsiveness of only inherently tmz sensitive gbm cells. j neurooncol, 2012. 110(3): p. 349-57.
[3]. rainey, m.d., et al., transient inhibition of atm kinase is sufficient to enhance cellular sensitivity to ionizing radiation. cancer res, 2008. 68(18): p. 7466-74. |
| | CP466722 Preparation Products And Raw materials |
|